Rankings
▼
Calendar
IRWD FY 2010 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$591M
FY 2010 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$44M
+21.5% YoY
Gross Profit
$44M
100.0% margin
Operating Income
-$61M
-138.6% margin
Net Income
-$53M
-120.8% margin
EPS (Diluted)
$-0.59
Cash Flow
Operating Cash Flow
-$68M
Free Cash Flow
-$85M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$301M
Total Liabilities
$142M
Stockholders' Equity
$160M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$44M
$36M
+21.5%
Gross Profit
$44M
$36M
+21.5%
Operating Income
-$61M
-$73M
+16.5%
Net Income
-$53M
-$71M
+25.6%
← FY 2009
All Quarters
FY 2011 →